| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/18/2002 | US20020045756 Preparation of camptothecin and of its derivatives |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045065 Novel organometallic luminescent materials and organic electroluminescent device containing same |
| 04/18/2002 | US20020045064 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines |
| 04/18/2002 | US20020045063 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines |
| 04/18/2002 | CA2424107A1 Sulfonylguanidines |
| 04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
| 04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP0805156B1 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1082950C Quinoline derivatives containing diol as leukotriene antagonists |
| 04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
| 04/16/2002 | US6371993 Hair dyes |
| 04/16/2002 | CA2162710C Dyes designed for high sensitivity detection of double-stranded dna |
| 04/16/2002 | CA2068429C Process for the purification of 7-chloroquinoline-8-carboxylic acids |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/11/2002 | WO2002028853A1 Benzylamine compound, process for producing the same, and intermediate therefor |
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | US20020042534 Method for producing an alpha-aminonitrile from a tertiary anime and a cyanide through oxidation with oxygen by using a transition metal catalyst |
| 04/11/2002 | US20020042516 That are microsomal triglyceride transfer protein (MTP) inhibitors useful for treating hypercholesterolemia for example; fewer synthesis steps, starting materials are an acyl halide and m-nitroaniline |
| 04/11/2002 | US20020042515 Tetrahydroquinolines |
| 04/11/2002 | US20020042423 Methods for identifying compounds that bind to hla molecules and use of such compounds as hla-agonists or antagonists |
| 04/11/2002 | US20020042414 Antiallergens |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/11/2002 | CA2419777A1 Pharmaceutical compounds |
| 04/10/2002 | EP1195372A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity |
| 04/10/2002 | EP1194429A1 Potassium channel openers |
| 04/10/2002 | EP1194418A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 04/10/2002 | CN1344254A Quinoline derivatives and quinazoline derivatives |
| 04/09/2002 | USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 04/09/2002 | US6369110 Substituted guanidine derivatives and process for producing the same |
| 04/09/2002 | US6369076 Analgesics |
| 04/09/2002 | US6369075 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B |
| 04/09/2002 | US6369053 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 04/09/2002 | CA2171675C Aromatic heterocyclic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 04/09/2002 | CA2071224C Quinoline derivatives, their production and use |
| 04/04/2002 | WO2002026730A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026713A1 Antiparasitic compounds |
| 04/04/2002 | WO2002026697A2 Aromatic derivatives with hiv integrase inhibitory properties |
| 04/04/2002 | WO2001066098A3 Therapeutic uses of ppar mediators |
| 04/04/2002 | WO2001047898A3 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 04/04/2002 | WO2001044197A3 2-phenyl-quinoline derivatives and their use as contracting agent for smooth muscles |
| 04/04/2002 | US20020040147 Novel catechols as antimicrobial agents |
| 04/04/2002 | US20020040143 Method of making metal 8-quinolinolato complexes |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020040022 Administering a therapeutically effective amount of a heterocyclic compound to the patient for the treatment of inosine monophosphate dehydrogenase associated disorders, such as allograft rejection |
| 04/04/2002 | US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423482A1 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/03/2002 | EP1192139A1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP0898567B1 N-aminoalkyl-1-biphenylenyl-2-carboxamides; dopamine receptor subtype specific ligands |
| 04/03/2002 | EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 04/02/2002 | US6365738 Reaction with hydrazine, hydroxylamine or urea. thiourea, guanidine or aniline |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 03/28/2002 | WO2002024703A1 Bicyclic heteroaromatic compounds |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024652A1 Compounds and methods for diagnosing and treating amyloid-related conditions |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | WO2002024617A1 Method for the isomerisation of allyl alcohols |
| 03/28/2002 | WO2002024225A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | US20020038029 Method for the synthesis of quinoline derivatives |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037931 Treating mood disorders, Parkinson's disease, disorders of the gastrointestinal system, edema formation states and hypertension; for example, 6,7-dihydroxy-8-nitro-3,4-dihydro-2H-naphthalen-1-one |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037885 Therapeutic compounds |
| 03/28/2002 | DE10046865A1 New tungstyl peroxide complexes useful as catalysts for isomerizing allylic alcohols, e.g. geraniol |
| 03/28/2002 | DE10046272A1 New biphenyl-substituted amino-(iso)quinoline derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or restenosis |
| 03/28/2002 | CA2422863A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | CA2416136A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1189903A1 Novel benzo f]naphthyridine, preparation and compositions containing them |
| 03/27/2002 | EP1189887A2 Process for preparing 10,11-methanobenzosuberane derivatives |
| 03/27/2002 | EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 03/27/2002 | EP0865421B1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 03/27/2002 | CN1342151A 喹啉和喹喔啉化合物 Quinoline and quinoxaline compounds |
| 03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362340 Method for preparing 4-hydroquinolines and/or tautomeric compounds |
| 03/26/2002 | US6362339 Electroluminescence |